IRC
INSM icon

Investors Research Corp’s Insmed INSM Stock Holding History

Investors Research Corp’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.83K Hold
16
– – ﹤0.01% 684
2026
Q2 		$1.71K Hold
16
– – ﹤0.01% 699
2026
Q1 		$2.62K Buy
+16
New +$2.46K ﹤0.01% 679

Other funds holding INSM

FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.62B AUM 25.73% 1-Year Est. Return
WWM
Whalen Wealth Management Las Vegas, Nevada $234M AUM 28.06% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
CI
CX Institutional Auburn, Indiana $3.69B AUM 15.82% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
GBT
Grove Bank & Trust Miami, Florida $1.01B AUM 19.76% 1-Year Est. Return
EWP
Elevation Wealth Partners Santa Rosa, California $356M AUM 17.04% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return

Investors Research Corp's INSM Position: Q3 2026 in Review

Investors Research Corp held its Insmed (INSM) position steady in Q3 2026 at 16 shares worth $1.83K. The position accounts for ﹤0.01% of the portfolio, ranked #684.

Investors Research Corp first reported a position in INSM in Q1 2026 and has held it in 3 quarters since. The position peaked at $2.62K in Q1 2026. 16 funds tracked by Wall St. Rank hold INSM as of Q3 2026.

  • Investors Research Corp held 16 shares of Insmed worth $1.83K as of Q3 2026.
  • Investors Research Corp left its Insmed share count unchanged in Q3 2026.
  • Insmed made up ﹤0.01% of Investors Research Corp's portfolio in Q3 2026, its #684 holding.
  • Investors Research Corp first reported a position in Insmed in Q1 2026 and has held it in 3 quarters since.
  • Investors Research Corp's Insmed position peaked at $2.62K in Q1 2026.
  • 16 funds tracked by Wall St. Rank held Insmed as of Q3 2026.

Based on Investors Research Corp's 13F filing for Q3 2026, filed 7 Oct 2026.